Can cirrhosis progress to liver cancer?

Patients with liver cirrhosis—especially those in the decompensated stage—often experience digestive dysfunction due to hepatic failure, leading to symptoms such as diarrhea, abdominal distension, and, in some cases, constipation. So, does cirrhosis progress to liver cancer? Let’s explore this further.

Does Cirrhosis Progress to Liver Cancer?

Indeed, a subset of patients with cirrhosis will develop hepatocellular carcinoma (HCC). This progression is well-documented in epidemiological studies: individuals with chronic hepatitis have a higher incidence of HCC than the general population, while patients with cirrhosis face an even greater risk than those with hepatitis alone. Thus, overall, patients with cirrhosis carry the highest risk of developing HCC. However, not all cirrhotic patients will progress to liver cancer.

While some patients with cirrhosis do not develop HCC, the disease itself causes progressive fibrosis of existing hepatocytes, resulting in loss of normal liver function and eventual hepatic decompensation. This may lead to complications such as esophageal and gastric varices, which—when triggered—can rupture, causing hematemesis (vomiting blood), melena (black tarry stools), or hepatic encephalopathy. These complications can ultimately prove fatal. Therefore, patients with viral hepatitis should receive prompt and active treatment to delay disease progression, prevent fibrosis, and avoid deterioration.

After clinical remission of hepatitis, patients should undergo liver function tests every six months and abdominal ultrasound annually to monitor hepatic status and prevent progression to cirrhosis. Patients diagnosed with cirrhosis require liver function testing every three months and abdominal ultrasound every six months.

For patients with chronic hepatitis B, antiviral therapy should be initiated based on hepatitis B virus (HBV) DNA levels to inhibit viral replication and halt disease progression. Commonly prescribed oral antiviral agents include entecavir and tenofovir disoproxil fumarate. Concurrent monitoring of liver function is essential during treatment.

Even after cirrhosis has developed, antiviral therapy remains beneficial and can slow disease progression. Patients with cirrhosis must strictly control their diet and completely abstain from alcohol—including beer and wine. They should also avoid spicy and irritating foods, such as chili peppers, Sichuan-style hotpot, and spicy skewers. Patients with ascites must rigorously restrict fluid intake.

We hope the above information is helpful to you.